EGR1 and neoplasm: Simultaneously, GSH in tumor cells would reduce MnO2 into Mn2+, thus activating the DNAzyme and enhancing the cleavage activity of DNAzyme on Egr-1 mRNA, which would down-regulate Egr-1 protein in tumor cells and achieve gene therapy.